Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) currently has a daily average trading volume of 1.70M but it saw 310332 shares traded in last market. With a market cap of 108.05M USD, the company’s current market price of $15.71 came falling about -0.95 while comparing to the previous closing price of $15.86. In past 52 weeks, the stock remained buoying in the range of price level as high as $672.00 and as low as $6.76. In the recent trading on the day, stock has struck highest price mark of $15.5 while lowest mark touched by it was $16.1981.
Taking a look at 20-day trading activity of Tonix Pharmaceuticals Holding Corp (TNXP) gives us an average price of $19.96, while its current price level is -97.66% below from 52-week high level whereas it is 132.40% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $15.14 while that of 200 days or SMA-200 reads an average of $26.36. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.42% during that period while stretching the period over a month that increases to 17.74%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 44.81 which implies that the stock is in neutral territory.
ROTH Capital upgraded its recommendation for the stock as a “Buy” from “Neutral” on April 18, 2019 while assigning a price target of $4. ROTH Capital issued its recommendations for the stock as it upgraded the price target for the stock is $6.
Over the week, TNXP’s stock price is moving -9.19% down while it is -4.61% when we observe its performance for the past one month. Year-to-date it is -52.37% down and over the past year, the stock is showing a downside performance of -96.72%.
Currently, Tonix Pharmaceuticals Holding Corp’s total number of outstanding shares is 4.39M. Company’s return on investment (ROI) stands at -89.94% and return on equity (ROE) at -106.12%. Stock’s beta reads 1.62. Stock has a price to book (P/B) ratio of 0.49 while price to sale or P/S ratio amounts to 10.71. Its return on asset (ROA) is -81.95% on average.
